Biocon said that its board has approved to raise Rs 4,500 crore, via multiple instruments through different routes.

Emkay Global has retained its 'Overweight', saying historical trends showed that the IT Index has always rallied when the ...

China on Thursday unveiled its 2025 negative list for market access. The new list cuts the number of restricted items from ...

UBS acknowledged India's strengths, noting its strong domestic orientation, resilience in earnings per share (EPS) even ...